Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate-free extension study in postmenopausal osteoporosis
NCT01249261Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Oct 2001
- Primary completion
- May 2003
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of risedronate in postmenopausal osteoporosis, sponsored by Warner Chilcott. Started Oct 2001; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01249261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249261.